9,532€
-0,78%
Echtzeit-Aktienkurs ASTELLAS PHARMA INC.
Bid:
Ask:
Echtzeit-Chart der ASTELLAS PHARMA INC. Aktie
Börsenkurse ASTELLAS PHARMA INC.
| Börse Stuttgart | - | - | - | - | 9,432€ | -2,35% |
| Tradegate | - | - | - | - | 9,488€ | -0,78% |
| Lang & Schwarz | - | - | - | - | 9,482€ | -0,90% |
| Echtzeit Euro | - | - | - | - | 9,487€ | -1,24% |
| Börse Frankfurt | - | - | - | - | 9,413€ | 2,20% |
| gettex | - | - | - | - | 9,532€ | -0,78% |
Profil der ASTELLAS PHARMA INC. Aktie
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.